Therapeutic targeting of Toll-like receptors

Drug Discovery Today: Therapeutic Strategies

Volumn 1, Issue 3, 2004, Pages 299-304

  Uematsu, Satoshi ^a   Ishii, Ken J ^b   Akira, Shizuo ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CELL WALL SKELETON; DNA VACCINE; HEAT SHOCK PROTEIN 70; I KAPPA B KINASE; IMIQUIMOD; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOLOGIC AGENT; INTERLEUKIN 1 RECEPTOR; LIGAND; MYCOBACTERIUM BOVIS CELL WALL SKELETON; MYELOID DIFFERENTIATION FACTOR 88; RESIQUIMOD; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TOLL LIKE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ACNE VULGARIS; ALLERGIC DISEASE; ANTINEOPLASTIC ACTIVITY; ASTHMA; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CANCER; CANCER IMMUNOTHERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONDYLOMA; CPG ISLAND; DRUG TARGETING; ENTERITIS; ENTEROCOLITIS; GENITAL HERPES; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MYCOSIS; NONHUMAN; PATHOGENESIS; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 13344281985     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2004.10.009     Document Type: Review

References (22)

1. C. Hashimoto et al. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein Cell 52 1988 269-279
2. B. Lemaitre et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults Cell 86 1996 973-983
3. R. Medzhitov et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 388 1997 394-397
4. A. Poltorak et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutation in Tlr4 gene Science 282 1998 2085-2088
5. S. Akira K. Takeda Toll-like receptor signalling Nat. Rev. Immunol. 4 2004 499-511
6. O. Adachi et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function Immunity 9 1998 143-150
7. T. Kawai et al. Unresponsiveness of MyD88-deficient mice to endotoxin Immunity 11 1999 115-122
8. T. Kawai et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IRF-3 and the expression of a subset of LPS-inducible genes J. Immunol. 167 2001 5887-5894
9. S.M. McWhirter et al. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts Proc. Natl. Acad. Sci. USA 101 2004 233-238
10. A.K. Perry et al. Differential Requirement for TANK-binding Kinase-1 in Type I interferon responses to Toll-like receptor activation and viral infection J. Exp. Med. 199 2004 1651-1658
11. H. Hemmi et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection J. Exp. Med. 199 2004 1641-1650
12. M. Yamamoto et al. Essential role of TIRAP/Mal for activation of the signaling cascade shared by TLR2 and TLR4 Nature 420 2002 324-329
13. M. Yamamoto et al. Cutting edge: A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling J. Immunol. 169 2002 6668-6672
14. M. Yamamoto et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway Science 301 2003 640-643
15. M. Yamamoto et al. TRAM is specifically involved in the TLR4-mediated MyD88-independent signaling pathway Nat. Immunol. 4 2003 1140-1150
16. L.A. O'Neill Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases Curr. Opin. Pharmacol. 3 2003 396-403
17. C. Zuany-Amorim et al. Toll-like receptors as potential therapeutic targets for multiple diseases Nat. Rev. Drug Discov. 1 2002 797-807
18. S. Akira et al. Toll-like receptors: Critical proteins linking innate and acquired immunity Nat. Immunol. 2 2001 675-680
19. M. Kobayashi et al. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice J. Clin. Invest. 111 2003 1297-1308
20. T. Seya et al. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer Anticancer Res. 23 2003 4369-4376
21. H. Hemmi et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nat. Immunol. 3 2002 196-200
22. H. Hemmi et al. A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740-745